Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.5496121905903717e-07,5.30404816388798,80.52687809214287,"['RPL41', 'RPL23', 'RPL23A', 'RPS6KA3', 'RPS25', 'RPS27', 'RPS6KA2', 'RPL27A', 'RPL37A', 'RPL36', 'RPL35', 'RPL24', 'RPL37', 'RPL26', 'RPL39', 'RPS13', 'RPS12']",8.592193082289552e-05,0,0,17
2,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.0038678378646247874,7.680400333611343,42.66508175390181,"['ACOX1', 'TBXAS1', 'PLA2G5', 'PTGDS']",0.49620778957709255,0,0,4
3,MAPK Signaling Pathway WP382,0.00538001426122716,2.1211691509475443,11.083245107359202,"['PDGFRB', 'JUND', 'DUSP1', 'CACNA1B', 'CACNA1A', 'CACNA1D', 'HSPA2', 'ARRB2', 'RASGRP1', 'MAPK10', 'RPS6KA3', 'PPP3CB', 'PPM1B', 'MRAS', 'NF1', 'MAPT', 'FGF22']",0.49620778957709255,0,0,17
4,Nuclear Receptors Meta-Pathway WP2882,0.008411921739309259,2.066200466200466,9.872523449332718,"['NCOA1', 'JUND', 'TXNRD1', 'GSR', 'SLC39A11', 'ARNT', 'IRS2', 'SLC39A12', 'SLC5A3', 'SLC6A9', 'DNAJC7', 'SLC39A9', 'ACOX1', 'FTH1', 'MFGE8', 'CAP2']",0.49620778957709255,0,0,16
5,Dopaminergic Neurogenesis WP2855,0.008834560051817672,9.038461538461538,42.74364357960476,"['NR4A2', 'ALDH1A1', 'GLI1']",0.49620778957709255,0,0,3
6,Eicosanoid Synthesis WP167,0.008834560051817672,9.038461538461538,42.74364357960476,"['TBXAS1', 'PLA2G5', 'PTGDS']",0.49620778957709255,0,0,3
7,Leptin Insulin Overlap WP3935,0.011742064715306543,7.907967032967033,35.14757321468862,"['IRS1', 'IRS2', 'DGKZ']",0.5652965441511865,0,0,3
8,Aryl Hydrocarbon Receptor Pathway WP2873,0.016113809265237207,4.69072375127421,19.36367660016032,"['NCOA1', 'JUND', 'ARNT', 'CAP2']",0.6681324101147535,0,0,4
9,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.017843298786447425,3.64255831643002,14.665403331622743,"['MAPK10', 'CTNNA1', 'MAP4K5', 'TEAD1', 'ACTG1']",0.6681324101147535,0,0,5
10,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.02088143321831286,3.020257826887661,11.685060035475681,"['SGCD', 'CTNNA1', 'ITGA7', 'CACNA1D', 'CTNNA2', 'ACTG1']",0.7037042994571434,0,0,6
11,Purinergic signaling WP4900,0.028292309138977432,5.27014652014652,18.78894335798854,"['GNAI3', 'ADORA1', 'GNAS']",0.7665214829281415,0,0,3
12,Nuclear receptors WP170,0.028559365789004712,3.8365304420350292,13.641821185082092,"['NR4A2', 'THRB', 'NR2F1', 'RORA']",0.7665214829281415,0,0,4
13,Regulation of Actin Cytoskeleton WP51,0.029569077976456495,2.097944488326384,7.386917355659276,"['PDGFRB', 'DIAPH1', 'PPP1R12A', 'MRAS', 'GSN', 'IQGAP1', 'DOCK1', 'FGF22', 'ACTG1', 'ARHGEF6']",0.7665214829281415,0,0,10
14,Adipogenesis WP236,0.03463956719644193,2.2569562538508934,7.589599254898569,"['NCOA1', 'MBNL1', 'IRS1', 'NR2F1', 'IRS2', 'RORA', 'PLIN2', 'LPIN2']",0.7782356096800619,0,0,8
15,NRF2 pathway WP2884,0.03463956719644193,2.2569562538508934,7.589599254898569,"['SLC6A9', 'SLC39A9', 'FTH1', 'TXNRD1', 'GSR', 'SLC39A11', 'SLC39A12', 'SLC5A3']",0.7782356096800619,0,0,8
16,IL-4 signaling pathway WP395,0.044343720805946986,2.7776702786377707,8.654621064159317,"['HRH1', 'IRS1', 'INPP5D', 'IRS2', 'JAK1']",0.8193979090427197,0,0,5
17,MED and Pseudoachondroplasia genes WP4789,0.04548069751388152,inf,inf,['COL9A2'],0.8193979090427197,0,0,1
18,Genes controlling nephrogenesis WP4823,0.04589762486110384,4.215018315018315,12.987912582111313,"['NOTCH2', 'PDGFRB', 'NCK2']",0.8193979090427197,0,0,3
19,Iron metabolism in placenta WP2007,0.048183102976994706,7.017672151127361,21.282823321402063,"['FTH1', 'ACO1']",0.8193979090427197,0,0,2
20,Zinc homeostasis WP3529,0.052720769482651225,3.9512362637362637,11.62748389322587,"['SLC39A9', 'SLC39A11', 'SLC39A12']",0.8193979090427197,0,0,3
21,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.05530856567294931,1.667709755329203,4.827732041433218,"['PDGFRB', 'ANGPT1', 'CAB39L', 'IRS1', 'COL11A1', 'IRS2', 'HIF3A', 'TBC1D1', 'PPP2R1B', 'GNG5', 'ITGA7', 'FGF22', 'JAK1', 'CREB5']",0.8193979090427197,0,0,14
22,Ebola Virus Pathway on Host WP4217,0.057722183957249026,2.013555144793592,5.742888231679341,"['GSN', 'CTSL', 'TYRO3', 'RAB9A', 'IQGAP1', 'MFGE8', 'ACTG1', 'HAVCR2']",0.8193979090427197,0,0,8
23,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.06285707760517632,1.8846534653465346,5.214632104569379,"['MAPK10', 'RPS6KA3', 'THRB', 'IRS1', 'RPS6KA2', 'IRS2', 'RICTOR', 'MAP4K5', 'RHOQ']",0.8193979090427197,0,0,9
24,Calcium Regulation in the Cardiac Cell WP536,0.06285707760517632,1.8846534653465346,5.214632104569379,"['GNG5', 'STIM2', 'CACNA1B', 'GNAS', 'GNAI3', 'CACNA1A', 'ATP1B3', 'CACNA1D', 'ARRB2']",0.8193979090427197,0,0,9
25,Circadian rhythm related genes WP3594,0.06377849273989723,1.8085089513660941,4.977630170557518,"['MAPK10', 'JUND', 'KCND2', 'PRKDC', 'CRY2', 'ADORA1', 'DYRK1A', 'ARNT', 'RORA', 'PTGDS']",0.8193979090427197,0,0,10
26,Wnt signaling in kidney disease WP4150,0.06772397568558283,3.5115995115995116,9.454332094338934,"['MAPK10', 'FZD3', 'WNT7A']",0.8193979090427197,0,0,3
27,Oxidative Stress WP408,0.06772397568558283,3.5115995115995116,9.454332094338934,"['MAPK10', 'TXNRD1', 'GSR']",0.8193979090427197,0,0,3
28,Alzheimer's disease WP2059,0.07004681358861564,2.1840350542960563,5.806457019926216,"['BACE1', 'PPP3CB', 'CAPN2', 'ADAM10', 'CACNA1D', 'MAPT']",0.8193979090427197,0,0,6
29,FOXA2 pathway WP5066,0.07294343403941125,5.262340036563072,13.777179917526185,"['IRS1', 'IRS2']",0.8193979090427197,0,0,2
30,Hypertrophy Model WP516,0.07294343403941125,5.262340036563072,13.777179917526185,"['JUND', 'ADAM10']",0.8193979090427197,0,0,2
31,Hedgehog Signaling Pathway WP4249,0.07918091931725717,2.635321100917431,6.683226825702672,"['GRK3', 'FBXL17', 'ARRB2', 'GLI1']",0.8607732196746989,0,0,4
32,Type II diabetes mellitus WP1584,0.08654375349684675,4.677229331708308,11.44567208898181,"['IRS1', 'CACNA1A']",0.8671548309906428,0,0,2
33,GPR40 Pathway WP3958,0.08654375349684675,4.677229331708308,11.44567208898181,"['PLCE1', 'PLCD1']",0.8671548309906428,0,0,2
34,Pathways affected in adenoid cystic carcinoma WP3651,0.09202366809989632,2.197074142156863,5.241580593967335,"['PRKDC', 'NFIB', 'ATRX', 'ERBIN', 'DTX4']",0.8671548309906428,0,0,5
35,Hippo-Merlin Signaling Dysregulation WP4541,0.09813829650902818,1.9782458563535912,4.59225563056672,"['PDGFRB', 'DDB1', 'PPP1R12A', 'CTNNA1', 'ITGA7', 'TEAD1']",0.8671548309906428,0,0,6
36,EGF/EGFR signaling pathway WP437,0.10161691263391899,1.6385497116394125,3.7466181333776487,"['VAV3', 'RPS6KA3', 'JUND', 'RPS6KA2', 'INPP5D', 'NCK2', 'PLCE1', 'RICTOR', 'IQGAP1', 'JAK1']",0.8671548309906428,0,0,10
37,Transcription factor regulation in adipogenesis WP3599,0.11569899012019114,3.8261592155559248,8.252120056351403,"['IRS1', 'IRS2']",0.8671548309906428,0,0,2
38,Omega-3/Omega-6 FA synthesis WP4723,0.11569899012019114,3.8261592155559248,8.252120056351403,"['ACOX1', 'PLA2G5']",0.8671548309906428,0,0,2
39,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.1244148078485857,1.6107344632768361,3.356986575229192,"['VAV3', 'MAPK10', 'RPS6KA3', 'CDKL5', 'IRS1', 'NCK2', 'IRS2', 'KCNN2', 'MAPT']",0.8671548309906428,0,0,9
40,Integrin-mediated Cell Adhesion WP185,0.12546226244552414,1.8340940027223958,3.807121109020509,"['VAV3', 'MAPK10', 'CAPN5', 'CAPN2', 'ITGA7', 'DOCK1']",0.8671548309906428,0,0,6
41,Fatty Acid Omega Oxidation WP206,0.1303412179054158,10.510948905109489,21.41710438132572,['ALDH1A1'],0.8671548309906428,0,0,1
42,Hypothetical Craniofacial Development Pathway WP3655,0.1303412179054158,10.510948905109489,21.41710438132572,['ARHGAP29'],0.8671548309906428,0,0,1
43,Ras signaling WP4223,0.14241005735761553,1.5573770491803278,3.0353974135042225,"['PDGFRB', 'MAPK10', 'SYNGAP1', 'MRAS', 'GNG5', 'NF1', 'PLCE1', 'PLA2G5', 'RASGRP1']",0.8671548309906428,0,0,9
44,Constitutive Androstane Receptor Pathway WP2875,0.14689457420681412,3.236956827450429,6.2086130998509965,"['NCOA1', 'DNAJC7']",0.8671548309906428,0,0,2
45,MAPK pathway in congenital thyroid cancer WP4928,0.14689457420681412,3.236956827450429,6.2086130998509965,"['ALK', 'GAREM2']",0.8671548309906428,0,0,2
46,Mitochondrial complex III assembly WP4921,0.14689457420681412,3.236956827450429,6.2086130998509965,"['UQCRB', 'UQCR10']",0.8671548309906428,0,0,2
47,Pregnane X receptor pathway WP2876,0.14689457420681412,3.236956827450429,6.2086130998509965,"['NCOA1', 'DNAJC7']",0.8671548309906428,0,0,2
48,Aryl Hydrocarbon Receptor Netpath WP2586,0.15415225952503564,2.339234839234839,4.373935143630191,"['PLAGL1', 'NF1', 'ARNT']",0.8671548309906428,0,0,3
49,Type 2 papillary renal cell carcinoma WP4241,0.15415225952503564,2.339234839234839,4.373935143630191,"['DIAPH1', 'ARNT', 'COL21A1']",0.8671548309906428,0,0,3
50,Complement system WP2806,0.15415225952503564,2.339234839234839,4.373935143630191,"['GNAI3', 'CD59', 'ARRB2']",0.8671548309906428,0,0,3
51,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.15415225952503564,2.339234839234839,4.373935143630191,"['IRS1', 'RICTOR', 'FBXO32']",0.8671548309906428,0,0,3
52,DNA IR-damage and cellular response via ATR WP4016,0.1578372137499612,1.816683569979716,3.3539449835367923,"['SMARCC2', 'RMI1', 'PRKDC', 'PPM1D', 'MCPH1']",0.8671548309906428,0,0,5
53,Transcription co-factors SKI and SKIL protein partners WP4533,0.1630690252213137,3.0054844606946984,5.450691618142533,"['NF1', 'TEAD1']",0.8671548309906428,0,0,2
54,Somatic sex determination WP4814,0.16990386326575815,7.00669099756691,12.419517528477225,['PTGDS'],0.8671548309906428,0,0,1
55,EDA signaling in hair follicle development WP3930,0.16990386326575815,7.00669099756691,12.419517528477225,['GLI1'],0.8671548309906428,0,0,1
56,Nucleotide GPCRs WP80,0.16990386326575815,7.00669099756691,12.419517528477225,['ADORA1'],0.8671548309906428,0,0,1
57,Osteoblast Signaling WP322,0.16990386326575815,7.00669099756691,12.419517528477225,['PDGFRB'],0.8671548309906428,0,0,1
58,Rett syndrome causing genes WP4312,0.1731925961581285,1.9145954962468723,3.356957987526781,"['SYNGAP1', 'CDKL5', 'KCNJ10', 'TBL1XR1']",0.8671548309906428,0,0,4
59,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.17661742913634887,2.1775293671845395,3.775333573098386,"['MAPK10', 'RPS6KA3', 'RPS6KA2']",0.8671548309906428,0,0,3
60,Focal Adhesion WP306,0.17685560352628657,1.4719638242894058,2.5500620393730307,"['VAV3', 'PDGFRB', 'MAPK10', 'DIAPH1', 'PPP1R12A', 'CAPN2', 'ITGA7', 'DOCK1', 'ACTG1']",0.8671548309906428,0,0,9
61,Sleep regulation WP3591,0.1795389245614857,2.804875076173065,4.816989361619819,"['ADORA1', 'PTGDS']",0.8671548309906428,0,0,2
62,Angiogenesis WP1539,0.1795389245614857,2.804875076173065,4.816989361619819,"['ANGPT1', 'ARNT']",0.8671548309906428,0,0,2
63,Canonical and non-canonical Notch signaling WP3845,0.1795389245614857,2.804875076173065,4.816989361619819,"['NOTCH2', 'ADAM10']",0.8671548309906428,0,0,2
64,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.1795389245614857,2.804875076173065,4.816989361619819,"['MRAS', 'RAB27A']",0.8671548309906428,0,0,2
65,Methionine De Novo and Salvage Pathway WP3580,0.1795389245614857,2.804875076173065,4.816989361619819,"['CHDH', 'ODC1']",0.8671548309906428,0,0,2
66,Regulatory circuits of the STAT3 signaling pathway WP4538,0.18230884248408374,1.8718858307849133,3.1860490686854455,"['PDGFRB', 'MAPK10', 'RICTOR', 'JAK1']",0.8671548309906428,0,0,4
67,Phosphoinositides metabolism WP4971,0.18817145485685569,2.104761904761905,3.5157979434674482,"['INPP5D', 'PLCE1', 'PLCD1']",0.8671548309906428,0,0,3
68,White fat cell differentiation WP4149,0.19624409219504174,2.6293418647166362,4.281609844124451,"['CTNNA1', 'RORA']",0.8671548309906428,0,0,2
69,Prostaglandin Synthesis and Regulation WP98,0.19624409219504174,2.6293418647166362,4.281609844124451,"['TBXAS1', 'PTGDS']",0.8671548309906428,0,0,2
70,Corticotropin-releasing hormone signaling pathway WP2355,0.19634607885880778,1.6717728758169934,2.721439724916351,"['NR4A2', 'GRK3', 'JUND', 'GNAS', 'ARRB2']",0.8671548309906428,0,0,5
71,Copper homeostasis WP3286,0.1999130439265125,2.0366891173342787,3.2788103862800506,"['BACE1', 'ADAM10', 'MAPT']",0.8671548309906428,0,0,3
72,G13 Signaling Pathway WP524,0.1999130439265125,2.0366891173342787,3.2788103862800506,"['MAPK10', 'DIAPH1', 'IQGAP1']",0.8671548309906428,0,0,3
73,Thermogenesis WP4321,0.20371969819738714,1.5607393765773139,2.4831523588619975,"['RPS6KA3', 'SMARCC2', 'RPS6KA2', 'GNAS', 'ACTG1', 'CREB5']",0.8671548309906428,0,0,6
74,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.2076698497630377,5.25456204379562,8.259150682146641,['JAK1'],0.8671548309906428,0,0,1
75,Nephrogenesis WP5052,0.2076698497630377,5.25456204379562,8.259150682146641,['NOTCH2'],0.8671548309906428,0,0,1
76,Role of Osx and miRNAs in tooth development WP3971,0.2076698497630377,5.25456204379562,8.259150682146641,['NOTCH2'],0.8671548309906428,0,0,1
77,SARS-CoV-2 and COVID-19 Pathway WP4846,0.2076698497630377,5.25456204379562,8.259150682146641,['CTSL'],0.8671548309906428,0,0,1
78,Pathways in clear cell renal cell carcinoma WP4018,0.2125877147458031,1.6200509049773755,2.5084877941262897,"['PDGFRB', 'PGM2', 'ARNT', 'PLOD2', 'PFKP']",0.8671548309906428,0,0,5
79,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.21312919302345637,2.4744596193139046,3.825160122755625,"['DYRK1A', 'RASGRP1']",0.8671548309906428,0,0,2
80,3q29 copy number variation syndrome WP4906,0.22021979290326363,1.7184796854521625,2.6002817447594855,"['CEP19', 'ADAM10', 'RABL2B', 'PIGM']",0.8671548309906428,0,0,4
81,Oncostatin M Signaling Pathway WP2374,0.22021979290326363,1.7184796854521625,2.6002817447594855,"['JUND', 'IRS1', 'RICTOR', 'JAK1']",0.8671548309906428,0,0,4
82,Osteoblast differentiation WP4787,0.2292390147390237,1.5714168129938542,2.3146813884828337,"['NOTCH2', 'MAPK10', 'FZD3', 'PRKDC', 'WNT7A']",0.8671548309906428,0,0,5
83,Sulfation Biotransformation Reaction WP692,0.2437206250986465,4.203284671532847,5.933914371060049,['GSR'],0.8671548309906428,0,0,1
84,Farnesoid X receptor pathway WP2879,0.2437206250986465,4.203284671532847,5.933914371060049,['IRS2'],0.8671548309906428,0,0,1
85,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2437206250986465,4.203284671532847,5.933914371060049,['ALDH1A1'],0.8671548309906428,0,0,1
86,Genes targeted by miRNAs in adipocytes WP1992,0.2437206250986465,4.203284671532847,5.933914371060049,['PTBP2'],0.8671548309906428,0,0,1
87,Glucuronidation WP698,0.2437206250986465,4.203284671532847,5.933914371060049,['PGM2'],0.8671548309906428,0,0,1
88,Insulin signaling in adipocytes (diabetic condition) WP3635,0.2437206250986465,4.203284671532847,5.933914371060049,['IRS1'],0.8671548309906428,0,0,1
89,Insulin signaling in adipocytes (normal condition) WP3634,0.2437206250986465,4.203284671532847,5.933914371060049,['IRS1'],0.8671548309906428,0,0,1
90,Peroxiredoxin 2 induced ovarian failure WP4873,0.2437206250986465,4.203284671532847,5.933914371060049,['MAPK10'],0.8671548309906428,0,0,1
91,"Phase I biotransformations, non P450 WP136",0.2437206250986465,4.203284671532847,5.933914371060049,['PON2'],0.8671548309906428,0,0,1
92,Pilocytic astrocytoma WP2253,0.2437206250986465,4.203284671532847,5.933914371060049,['NF1'],0.8671548309906428,0,0,1
93,EPO Receptor Signaling WP581,0.24724020782422818,2.213605311267199,3.093280802714906,"['IRS1', 'IRS2']",0.8671548309906428,0,0,2
94,One-carbon metabolism and related pathways WP3940,0.24836962862872528,1.8032967032967033,2.5116987389207313,"['CHDH', 'GSR', 'CDO1']",0.8671548309906428,0,0,3
95,ATM Signaling Network in Development and Disease  WP3878,0.2607641292039586,1.753052503052503,2.356346238023913,"['PRKDC', 'PPM1D', 'HMGN1']",0.8671548309906428,0,0,3
96,PI3K-Akt signaling pathway WP4172,0.26347116982525187,1.2739490992279097,1.6992077416476887,"['PDGFRB', 'PPP2R1B', 'GNG5', 'ANGPT1', 'IRS1', 'ITGA7', 'COL9A2', 'SGK2', 'FGF22', 'JAK1', 'CREB5']",0.8671548309906428,0,0,11
97,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.2643769339562304,2.1027422303473493,2.7974449762182863,"['SERPINH1', 'PLOD2']",0.8671548309906428,0,0,2
98,Vitamin A and carotenoid metabolism WP716,0.2643769339562304,2.1027422303473493,2.7974449762182863,"['ALDH1A1', 'RBP1']",0.8671548309906428,0,0,2
99,Hematopoietic Stem Cell Differentiation WP2849,0.2643769339562304,2.1027422303473493,2.7974449762182863,"['THRB', 'MXI1']",0.8671548309906428,0,0,2
100,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.2643769339562304,2.1027422303473493,2.7974449762182863,"['CARD8', 'ERBIN']",0.8671548309906428,0,0,2
101,VEGFA-VEGFR2 Signaling Pathway WP3888,0.27164678361490635,1.1862007368538574,1.5459192492712,"['USP10', 'LARP7', 'ARNT', 'ADAM10', 'PDE4DIP', 'PTPRJ', 'NAP1L1', 'PLA2G5', 'IQGAP1', 'ARRB2', 'ACTG1', 'NR4A2', 'MOV10', 'CSRP1', 'CTNNA1', 'CAPN2', 'RICTOR', 'RPL26', 'TKT']",0.8671548309906428,0,0,19
102,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.27323575047129356,1.7055242055242055,2.2127817291279492,"['MAPK10', 'RPS6KA2', 'EIF4G3']",0.8671548309906428,0,0,3
103,Type III interferon signaling WP2113,0.278133952110388,3.502433090024331,4.481897046842014,['JAK1'],0.8671548309906428,0,0,1
104,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.278133952110388,3.502433090024331,4.481897046842014,['JAK1'],0.8671548309906428,0,0,1
105,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.278133952110388,3.502433090024331,4.481897046842014,['CDO1'],0.8671548309906428,0,0,1
106,Pentose Phosphate Metabolism WP134,0.278133952110388,3.502433090024331,4.481897046842014,['TKT'],0.8671548309906428,0,0,1
107,Head and Neck Squamous Cell Carcinoma WP4674,0.28035988447582194,1.530208507089241,1.9459373896375225,"['NOTCH2', 'SESN1', 'FAT1', 'RICTOR']",0.8671548309906428,0,0,4
108,Energy Metabolism WP1541,0.2857679872296589,1.6604973973395025,2.0798975787037652,"['NCOA1', 'PPP3CB', 'NRF1']",0.8671548309906428,0,0,3
109,Genotoxicity pathway WP4286,0.2857679872296589,1.6604973973395025,2.0798975787037652,"['RPS27', 'PPM1D', 'TOPORS']",0.8671548309906428,0,0,3
110,ESC Pluripotency Pathways WP3931,0.29006084682052946,1.4218998410174881,1.7598350430699095,"['PDGFRB', 'FZD3', 'WNT7A', 'FGF22', 'JAK1']",0.8671548309906428,0,0,5
111,Exercise-induced Circadian Regulation WP410,0.29834493928898226,1.6177796562411948,1.9567124981682653,"['PURA', 'VAPA', 'CRY2']",0.8671548309906428,0,0,3
112,Insulin Signaling WP481,0.29844674433446394,1.2858291825993706,1.5547780658736217,"['MAPK10', 'RPS6KA3', 'IRS1', 'RPS6KA2', 'IRS2', 'MAP4K5', 'SGK2', 'RHOQ']",0.8671548309906428,0,0,8
113,Sphingolipid pathway WP1422,0.29861795694772647,1.911251454213063,2.3099198892068555,"['SPTLC3', 'PLPP1']",0.8671548309906428,0,0,2
114,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.29861795694772647,1.911251454213063,2.3099198892068555,"['ANGPT1', 'ARNT']",0.8671548309906428,0,0,2
115,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.31095132384299695,1.5771978021978021,1.842354552365011,"['VAV3', 'JUND', 'CTNNA1']",0.8671548309906428,0,0,3
116,Thiamine metabolic pathways WP4297,0.31098407452202953,3.0018248175182483,3.5061721379501325,['TKT'],0.8671548309906428,0,0,1
117,Development and heterogeneity of the ILC family WP3893,0.31098407452202953,3.0018248175182483,3.5061721379501325,['RORA'],0.8671548309906428,0,0,1
118,Estrogen Receptor Pathway WP2881,0.31098407452202953,3.0018248175182483,3.5061721379501325,['ACOX1'],0.8671548309906428,0,0,1
119,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.31098407452202953,3.0018248175182483,3.5061721379501325,['STAG1'],0.8671548309906428,0,0,1
120,16p11.2 proximal deletion syndrome WP4949,0.3113523280411507,1.4506801645049034,1.6926973110745078,"['PPP4R1', 'ASPHD1', 'PPP4R4', 'KCTD13']",0.8671548309906428,0,0,4
121,Prolactin Signaling Pathway WP2037,0.3113523280411507,1.4506801645049034,1.6926973110745078,"['IRS1', 'RPS6KA2', 'IRS2', 'JAK1']",0.8671548309906428,0,0,4
122,Resistin as a regulator of inflammation WP4481,0.3156545112517415,1.8279945950242429,2.10787333118001,"['PLCE1', 'PLCD1']",0.8719309040314498,0,0,2
123,15q13.3 copy number variation syndrome WP4942,0.3423418759711784,2.6263686131386863,2.815323763752886,['SERPINH1'],0.8791557418098427,0,0,1
124,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.3423418759711784,2.6263686131386863,2.815323763752886,['JAK1'],0.8791557418098427,0,0,1
125,NLR Proteins WP288,0.3423418759711784,2.6263686131386863,2.815323763752886,['ERBIN'],0.8791557418098427,0,0,1
126,Interferon type I signaling pathways WP585,0.34880366052992323,1.4667774086378738,1.544877574015399,"['IRS1', 'IRS2', 'JAK1']",0.8791557418098427,0,0,3
127,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.35330981485296087,1.2982253086419753,1.3506865213079775,"['SLC25A27', 'UQCRB', 'NDUFS3', 'UQCR10', 'ATP5MF']",0.8791557418098427,0,0,5
128,Myometrial relaxation and contraction pathways WP289,0.3598923033520138,1.249494010174498,1.2769209655252962,"['GNG5', 'GNAS', 'ARRB2', 'DGKZ', 'PLCD1', 'ACTG1']",0.8791557418098427,0,0,6
129,Amino Acid metabolism WP3925,0.3635549634607163,1.3349643221202854,1.350749991175341,"['RARS', 'ALDH1A1', 'ODC1', 'GSR']",0.8791557418098427,0,0,4
130,Pathways Regulating Hippo Signaling WP4540,0.3635549634607163,1.3349643221202854,1.350749991175341,"['PDGFRB', 'GNAS', 'GNAI3', 'TEAD1']",0.8791557418098427,0,0,4
131,Alpha 6 Beta 4 signaling pathway WP244,0.36608489224571433,1.616650260160315,1.6245557226921703,"['IRS1', 'IRS2']",0.8791557418098427,0,0,2
132,TCA cycle in senescence WP5050,0.37227503151564123,2.3343471208434714,2.3066205997606257,['ME2'],0.8791557418098427,0,0,1
133,Glutathione metabolism WP100,0.37227503151564123,2.3343471208434714,2.3066205997606257,['GSR'],0.8791557418098427,0,0,1
134,miR-509-3p alteration of YAP1/ECM axis WP3967,0.37227503151564123,2.3343471208434714,2.3066205997606257,['TEAD1'],0.8791557418098427,0,0,1
135,Monoamine GPCRs WP58,0.37227503151564123,2.3343471208434714,2.3066205997606257,['HRH1'],0.8791557418098427,0,0,1
136,Non-homologous end joining WP438,0.37227503151564123,2.3343471208434714,2.3066205997606257,['PRKDC'],0.8791557418098427,0,0,1
137,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.37227503151564123,2.3343471208434714,2.3066205997606257,['RNASEH2C'],0.8791557418098427,0,0,1
138,Kit receptor signaling pathway WP304,0.37393384833191773,1.4013431013431012,1.3784680997200527,"['RPS6KA3', 'INPP5D', 'MAPT']",0.8791557418098427,0,0,3
139,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.37393384833191773,1.4013431013431012,1.3784680997200527,"['PLCE1', 'PLCD1', 'JAK1']",0.8791557418098427,0,0,3
140,PDGFR-beta pathway WP3972,0.38258881296106867,1.5566389058162367,1.4956100399170662,"['PDGFRB', 'JAK1']",0.8791557418098427,0,0,2
141,Wnt signaling pathway and pluripotency WP399,0.39485739930752545,1.2739505143174867,1.1837937927301967,"['MAPK10', 'FZD3', 'PPP2R1B', 'WNT7A']",0.8791557418098427,0,0,4
142,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.39485739930752545,1.2739505143174867,1.1837937927301967,"['PDGFRB', 'MRAS', 'NF1', 'JAK1']",0.8791557418098427,0,0,4
143,Tumor suppressor activity of SMARCB1 WP4204,0.3989057052428983,1.5009140767824498,1.3793853907855538,"['SMARCC2', 'GLI1']",0.8791557418098427,0,0,2
144,Imatinib and Chronic Myeloid Leukemia WP3640,0.4008481526617723,2.100729927007299,1.9204297288844658,['PDGFRB'],0.8791557418098427,0,0,1
145,Mammalian disorder of sexual development WP4842,0.4008481526617723,2.100729927007299,1.9204297288844658,['PTGDS'],0.8791557418098427,0,0,1
146,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.41123558385824666,1.313415750915751,1.167086830673823,"['CTSL', 'FAT1', 'PLCE1']",0.8791557418098427,0,0,3
147,Cori Cycle WP1946,0.428122925790894,1.909588586595886,1.6199897668853747,['PFKP'],0.8791557418098427,0,0,1
148,Cysteine and methionine catabolism WP4504,0.428122925790894,1.909588586595886,1.6199897668853747,['CDO1'],0.8791557418098427,0,0,1
149,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.428122925790894,1.909588586595886,1.6199897668853747,['RAB27A'],0.8791557418098427,0,0,1
150,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.428122925790894,1.909588586595886,1.6199897668853747,['ACOX1'],0.8791557418098427,0,0,1
151,Amyotrophic lateral sclerosis (ALS) WP2447,0.43091183850864834,1.4006093845216332,1.1791054765887063,"['PPP3CB', 'NEFH']",0.8791557418098427,0,0,2
152,Disruption of postsynaptic signaling by CNV WP4875,0.43091183850864834,1.4006093845216332,1.1791054765887063,"['SYNGAP1', 'DLGAP1']",0.8791557418098427,0,0,2
153,IL-5 signaling pathway WP127,0.43091183850864834,1.4006093845216332,1.1791054765887063,"['MAPT', 'JAK1']",0.8791557418098427,0,0,2
154,Target Of Rapamycin (TOR) Signaling WP1471,0.4465725026322416,1.3553104912425546,1.0925883122739304,"['RRAGD', 'RICTOR']",0.8791557418098427,0,0,2
155,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4465725026322416,1.3553104912425546,1.0925883122739304,"['PRKDC', 'ACTG1']",0.8791557418098427,0,0,2
156,IL-2 signaling pathway WP49,0.4465725026322416,1.3553104912425546,1.0925883122739304,"['MAPT', 'JAK1']",0.8791557418098427,0,0,2
157,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.44782157376341275,1.2358327946563241,0.9928191267014205,"['FZD3', 'H2AFY2', 'WNT7A']",0.8791557418098427,0,0,3
158,Integrated breast cancer pathway WP1984,0.4498583226599977,1.1256906077348066,0.8992270804190337,"['FER', 'RASGEF1A', 'IRS1', 'ODC1', 'NF1', 'JAK1']",0.8791557418098427,0,0,6
159,Endoderm differentiation WP2853,0.45316033362378133,1.1419037723785166,0.9038274312895724,"['VAV3', 'SESN1', 'UBR5', 'NAA15', 'PARP8']",0.8791557418098427,0,0,5
160,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.45415824427442597,1.7503041362530414,1.3815318331628867,['NRF1'],0.8791557418098427,0,0,1
161,Hedgehog Signaling Pathway Netpath WP47,0.45415824427442597,1.7503041362530414,1.3815318331628867,['GLI1'],0.8791557418098427,0,0,1
162,IL-9 signaling pathway WP22,0.45415824427442597,1.7503041362530414,1.3815318331628867,['JAK1'],0.8791557418098427,0,0,1
163,Chemokine signaling pathway WP3929,0.46208619758137864,1.1295264073371285,0.8719987130607824,"['VAV3', 'GNG5', 'PARD3', 'GNAI3', 'ARRB2']",0.8791557418098427,0,0,5
164,Mesodermal commitment pathway WP2857,0.46208619758137864,1.1295264073371285,0.8719987130607824,"['VAV3', 'SESN1', 'UBR5', 'TEAD1', 'PARP8']",0.8791557418098427,0,0,5
165,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4716987595237899,1.188990255027991,0.8934247777744726,"['GNAI3', 'GNAS', 'JAK1']",0.8791557418098427,0,0,3
166,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4716987595237899,1.188990255027991,0.8934247777744726,"['PRKN', 'PSMD6', 'HSPA2']",0.8791557418098427,0,0,3
167,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4771502889271881,1.2729488670987756,0.9418851204228719,"['JAK1', 'HAVCR2']",0.8791557418098427,0,0,2
168,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.47901033476317606,1.6155249859629421,1.1890798733971832,['DKK3'],0.8791557418098427,0,0,1
169,SARS coronavirus and innate immunity WP4912,0.47901033476317606,1.6155249859629421,1.1890798733971832,['JAK1'],0.8791557418098427,0,0,1
170,Common Pathways Underlying Drug Addiction WP2636,0.4920484795029866,1.2354016560920529,0.8761197149114804,"['GNAS', 'ACTG1']",0.8791557418098427,0,0,2
171,IL-6 signaling pathway WP364,0.4920484795029866,1.2354016560920529,0.8761197149114804,"['NCOA1', 'JAK1']",0.8791557418098427,0,0,2
172,Notch Signaling WP268,0.4920484795029866,1.2354016560920529,0.8761197149114804,"['NOTCH2', 'DTX4']",0.8791557418098427,0,0,2
173,PDGF Pathway WP2526,0.4920484795029866,1.2354016560920529,0.8761197149114804,"['PDGFRB', 'JAK1']",0.8791557418098427,0,0,2
174,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.5027328777086858,1.5,1.0315444622654906,['ACO1'],0.8791557418098427,0,0,1
175,Triacylglyceride synthesis WP325,0.5027328777086858,1.5,1.0315444622654906,['PLPP1'],0.8791557418098427,0,0,1
176,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.5027328777086858,1.5,1.0315444622654906,['LPP'],0.8791557418098427,0,0,1
177,Overview of interferons-mediated signaling pathway WP4558,0.5027328777086858,1.5,1.0315444622654906,['JAK1'],0.8791557418098427,0,0,1
178,Breast cancer pathway WP4262,0.5060002609752385,1.0714285714285714,0.7298765292144253,"['NOTCH2', 'NCOA1', 'FZD3', 'WNT7A', 'FGF22']",0.8791557418098427,0,0,5
179,Netrin-UNC5B signaling pathway WP4747,0.5066758515051448,1.2,0.8158605912042646,"['PPP2R1B', 'INPP5D']",0.8791557418098427,0,0,2
180,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5210261896464757,1.166565102579728,0.7605479169881878,"['SERPINH1', 'SLC38A2']",0.8791557418098427,0,0,2
181,Endochondral Ossification WP474,0.5210261896464757,1.166565102579728,0.7605479169881878,"['SERPINH1', 'SLC38A2']",0.8791557418098427,0,0,2
182,IL-3 signaling pathway WP286,0.5210261896464757,1.166565102579728,0.7605479169881878,"['INPP5D', 'JAK1']",0.8791557418098427,0,0,2
183,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5253771224201103,1.3998783454987835,0.9010162226089613,['GNAS'],0.8791557418098427,0,0,1
184,Apoptosis Modulation by HSP70 WP384,0.5253771224201103,1.3998783454987835,0.9010162226089613,['MAPK10'],0.8791557418098427,0,0,1
185,Urea cycle and metabolism of amino groups WP497,0.5253771224201103,1.3998783454987835,0.9010162226089613,['ODC1'],0.8791557418098427,0,0,1
186,Microglia Pathogen Phagocytosis Pathway WP3937,0.5253771224201103,1.3998783454987835,0.9010162226089613,['VAV3'],0.8791557418098427,0,0,1
187,Mitochondrial Gene Expression WP391,0.5253771224201103,1.3998783454987835,0.9010162226089613,['NRF1'],0.8791557418098427,0,0,1
188,Retinoblastoma gene in cancer WP2446,0.529190447556506,1.086017430845017,0.6911489839350076,"['PRKDC', 'RBP1', 'HMGB2']",0.8791557418098427,0,0,3
189,Ectoderm Differentiation WP2858,0.5316582182711632,1.039330955154339,0.6566019486211029,"['STX16', 'HMGB2', 'CTNNA2', 'ANKS1B', 'CAP2']",0.8791557418098427,0,0,5
190,Regulation of Microtubule Cytoskeleton WP2038,0.535094401262108,1.1349374969119028,0.7096901458112558,"['DIAPH1', 'MAPT']",0.8791557418098427,0,0,2
191,Cell cycle WP179,0.5351372613511705,1.049724770642202,0.6563215196033171,"['STAG1', 'PRKDC', 'ORC3', 'CDC27']",0.8791557418098427,0,0,4
192,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5469919970781862,1.312271897810219,0.7917213343831586,['RASGRP1'],0.8791557418098427,0,0,1
193,Monoamine Transport WP727,0.5469919970781862,1.312271897810219,0.7917213343831586,['FBXO32'],0.8791557418098427,0,0,1
194,One-carbon metabolism WP241,0.5469919970781862,1.312271897810219,0.7917213343831586,['CHDH'],0.8791557418098427,0,0,1
195,Ciliopathies WP4803,0.548343945733698,1.0063185563362482,0.6046490714079016,"['CEP19', 'NME9', 'EFHC1', 'BBS9', 'PKD1L1', 'BBIP1', 'TOPORS']",0.8791557418098427,0,0,7
196,Pathogenic Escherichia coli infection WP2272,0.5488764273466626,1.1049745020687,0.6628542585688658,"['NCK2', 'ACTG1']",0.8791557418098427,0,0,2
197,Vitamin D Receptor Pathway WP2877,0.551192290911637,1.0496336996336997,0.6252369279540823,"['CD9', 'TRAK1', 'RASGRP1']",0.8791557418098427,0,0,3
198,Eukaryotic Transcription Initiation WP405,0.5623691594534495,1.0765480710636104,0.6196576003950878,"['POLR1A', 'GTF2H3']",0.8791557418098427,0,0,2
199,"GPCRs, Class A Rhodopsin-like WP455",0.5623691594534495,1.0765480710636104,0.6196576003950878,"['HRH1', 'ADORA1']",0.8791557418098427,0,0,2
200,Striated Muscle Contraction Pathway WP383,0.567624213580312,1.2349720910261914,0.699359353920242,['ACTG1'],0.8791557418098427,0,0,1
201,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.567624213580312,1.2349720910261914,0.699359353920242,['JAK1'],0.8791557418098427,0,0,1
202,Differentiation Pathway WP2848,0.567624213580312,1.2349720910261914,0.699359353920242,['ALK'],0.8791557418098427,0,0,1
203,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.567624213580312,1.2349720910261914,0.699359353920242,['CBX5'],0.8791557418098427,0,0,1
204,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.567624213580312,1.2349720910261914,0.699359353920242,['H2AFY2'],0.8791557418098427,0,0,1
205,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.567624213580312,1.2349720910261914,0.699359353920242,['ATG10'],0.8791557418098427,0,0,1
206,Immune response to tuberculosis WP4197,0.567624213580312,1.2349720910261914,0.699359353920242,['JAK1'],0.8791557418098427,0,0,1
207,miRNA regulation of p53 pathway in prostate cancer WP3982,0.567624213580312,1.2349720910261914,0.699359353920242,['ZMAT3'],0.8791557418098427,0,0,1
208,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5755703618298748,1.049542961608775,0.5797610208471654,"['PPP1R12A', 'PPP1R8']",0.8791557418098427,0,0,2
209,Nucleotide Excision Repair WP4753,0.5755703618298748,1.049542961608775,0.5797610208471654,"['DDB1', 'GTF2H3']",0.8791557418098427,0,0,2
210,Leptin signaling pathway WP2034,0.5830264272541483,0.9993894993894994,0.5391933849152942,"['NCOA1', 'IRS1', 'JAK1']",0.8791557418098427,0,0,3
211,7-oxo-C and 7beta-HC pathways WP5064,0.5873183677435017,1.1662611516626116,0.6206704720764964,['ACOT11'],0.8791557418098427,0,0,1
212,Signal Transduction of S1P Receptor WP26,0.5873183677435017,1.1662611516626116,0.6206704720764964,['GNAI3'],0.8791557418098427,0,0,1
213,Cannabinoid receptor signaling WP3869,0.5873183677435017,1.1662611516626116,0.6206704720764964,['MAPK10'],0.8791557418098427,0,0,1
214,TYROBP causal network in microglia WP3945,0.5873183677435017,1.1662611516626116,0.6206704720764964,['ADAP2'],0.8791557418098427,0,0,1
215,Vitamin D in inflammatory diseases WP4482,0.5873183677435017,1.1662611516626116,0.6206704720764964,['DUSP1'],0.8791557418098427,0,0,1
216,Glycerolipids and Glycerophospholipids WP4722,0.5873183677435017,1.1662611516626116,0.6206704720764964,['DGKZ'],0.8791557418098427,0,0,1
217,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5873183677435017,1.1662611516626116,0.6206704720764964,['GLI1'],0.8791557418098427,0,0,1
218,Hippo-Yap signaling pathway WP4537,0.5873183677435017,1.1662611516626116,0.6206704720764964,['TEAD1'],0.8791557418098427,0,0,1
219,IL-7 signaling pathway WP205,0.5873183677435017,1.1662611516626116,0.6206704720764964,['JAK1'],0.8791557418098427,0,0,1
220,PKC-gamma calcium signaling pathway in ataxia WP4760,0.5873183677435017,1.1662611516626116,0.6206704720764964,['CACNA1A'],0.8791557418098427,0,0,1
221,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5884785986444738,1.0238551745663709,0.5428630835593922,"['SYNGAP1', 'NF1']",0.8791557418098427,0,0,2
222,Synaptic Vesicle Pathway WP2267,0.5884785986444738,1.0238551745663709,0.5428630835593922,"['CACNA1B', 'CACNA1A']",0.8791557418098427,0,0,2
223,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5884785986444738,1.0238551745663709,0.5428630835593922,"['PRKDC', 'MCPH1']",0.8791557418098427,0,0,2
224,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5884785986444738,1.0238551745663709,0.5428630835593922,"['DDX17', 'MAPK10']",0.8791557418098427,0,0,2
225,Selenium Micronutrient Network WP15,0.6010931664528284,0.9993906154783668,0.5086951574308117,"['TXNRD1', 'GSR']",0.8791557418098427,0,0,2
226,Glioblastoma signaling pathways WP2261,0.6034360747719437,0.9684699915469146,0.48918888268729477,"['PDGFRB', 'IRS1', 'NF1']",0.8791557418098427,0,0,3
227,Endothelin Pathways WP2197,0.6061170350227602,1.1047829427583558,0.5531451371335124,['GNAS'],0.8791557418098427,0,0,1
228,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6061170350227602,1.1047829427583558,0.5531451371335124,['MFGE8'],0.8791557418098427,0,0,1
229,Nanoparticle triggered autophagic cell death WP2509,0.6061170350227602,1.1047829427583558,0.5531451371335124,['ATG10'],0.8791557418098427,0,0,1
230,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.6134140302734041,0.9760639428595723,0.47701724073799756,"['FZD3', 'WNT7A']",0.8791557418098427,0,0,2
231,TLR4 Signaling and Tolerance WP3851,0.6240608620117447,1.0494525547445255,0.4948246246202663,['INPP5D'],0.8791557418098427,0,0,1
232,Cell migration and invasion through p75NTR WP4561,0.6240608620117447,1.0494525547445255,0.4948246246202663,['PARD3'],0.8791557418098427,0,0,1
233,Tryptophan metabolism WP465,0.6240608620117447,1.0494525547445255,0.4948246246202663,['ALDH1A1'],0.8791557418098427,0,0,1
234,Type II interferon signaling (IFNG) WP619,0.6240608620117447,1.0494525547445255,0.4948246246202663,['JAK1'],0.8791557418098427,0,0,1
235,Estrogen signaling pathway WP712,0.6240608620117447,1.0494525547445255,0.4948246246202663,['GNAS'],0.8791557418098427,0,0,1
236,Fluoropyrimidine Activity WP1601,0.6240608620117447,1.0494525547445255,0.4948246246202663,['UPP2'],0.8791557418098427,0,0,1
237,Pre-implantation embryo WP3527,0.6240608620117447,1.0494525547445255,0.4948246246202663,['H2AFY2'],0.8791557418098427,0,0,1
238,SARS-CoV-2 mitochondrial interactions WP5038,0.6240608620117447,1.0494525547445255,0.4948246246202663,['CTSL'],0.8791557418098427,0,0,1
239,Ethanol effects on histone modifications WP3996,0.6411886534618283,0.9993917274939172,0.44416121869435626,['ALDH1A1'],0.8791557418098427,0,0,1
240,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6411886534618283,0.9993917274939172,0.44416121869435626,['TEAD1'],0.8791557418098427,0,0,1
241,Physiological and pathological hypertrophy of the heart WP1528,0.6411886534618283,0.9993917274939172,0.44416121869435626,['PPP3CB'],0.8791557418098427,0,0,1
242,Pyrimidine metabolism WP4022,0.64223307152698,0.912008281573499,0.4038409164030083,"['PNPT1', 'POLR1A', 'UPRT']",0.8791557418098427,0,0,3
243,DNA damage response WP707,0.6486228654583066,0.912169143947222,0.3948815180032626,"['PRKDC', 'SESN1']",0.8791557418098427,0,0,2
244,Pancreatic adenocarcinoma pathway WP4263,0.6515040087238018,0.8989010989010989,0.38515370837710017,"['MAPK10', 'JAK1', 'ARHGEF6']",0.8791557418098427,0,0,3
245,MTHFR deficiency WP4288,0.6575374556515744,0.9538818845388188,0.39991836616593646,['CHDH'],0.8791557418098427,0,0,1
246,AGE/RAGE pathway WP2324,0.6597799506386152,0.8926834960519663,0.37122145673522916,"['DIAPH1', 'IRS1']",0.8791557418098427,0,0,2
247,Mitochondrial complex I assembly model OXPHOS system WP4324,0.6597799506386152,0.8926834960519663,0.37122145673522916,"['NDUFS3', 'NDUFAF2']",0.8791557418098427,0,0,2
248,p53 transcriptional gene network WP4963,0.6597799506386152,0.8926834960519663,0.37122145673522916,"['ZMAT3', 'SESN1']",0.8791557418098427,0,0,2
249,Male infertility WP4673,0.6606023163882281,0.8861631326420059,0.3674061232777138,"['PON2', 'CHD2', 'PUM2']",0.8791557418098427,0,0,3
250,Wnt signaling WP428,0.669527775818001,0.8737789987789988,0.3505449544149303,"['FZD3', 'PPP3CB', 'WNT7A']",0.8791557418098427,0,0,3
251,miRNA regulation of DNA damage response WP1530,0.6706512521510339,0.8740097501523462,0.3491721572183544,"['PRKDC', 'SESN1']",0.8791557418098427,0,0,2
252,Notch Signaling Pathway Netpath WP61,0.6706512521510339,0.8740097501523462,0.3491721572183544,"['NOTCH2', 'MAPT']",0.8791557418098427,0,0,2
253,Oxidative phosphorylation WP623,0.6706512521510339,0.8740097501523462,0.3491721572183544,"['NDUFS3', 'ATP5MF']",0.8791557418098427,0,0,2
254,mRNA Processing WP411,0.6708022136263782,0.8807309688581315,0.35165909711118204,"['PRPF6', 'SF3B3', 'PRPF40A', 'SREK1', 'PTBP2']",0.8791557418098427,0,0,5
255,Glycerophospholipid Biosynthetic Pathway WP2533,0.6731426360994789,0.9123294192319898,0.3610981878294937,['LPIN2'],0.8791557418098427,0,0,1
256,Nanoparticle-mediated activation of receptor signaling WP2643,0.6731426360994789,0.9123294192319898,0.3610981878294937,['MAPK10'],0.8791557418098427,0,0,1
257,Neovascularisation processes WP4331,0.6731426360994789,0.9123294192319898,0.3610981878294937,['ANGPT1'],0.8791557418098427,0,0,1
258,Oxysterols derived from cholesterol WP4545,0.6731426360994789,0.9123294192319898,0.3610981878294937,['ACOT11'],0.8791557418098427,0,0,1
259,Nonalcoholic fatty liver disease WP4396,0.6776786345435564,0.8733149509803921,0.3397912096388501,"['UQCRB', 'IRS1', 'NDUFS3', 'IRS2', 'UQCR10']",0.8791557418098427,0,0,5
260,G Protein Signaling Pathways WP35,0.678280394274656,0.8617341562547042,0.3345204734127306,"['GNG5', 'GNAI3', 'GNAS']",0.8791557418098427,0,0,3
261,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6812396364724187,0.8560981979629146,0.32860571308466563,"['FZD3', 'NEFH']",0.879608266249828,0,0,2
262,DNA Repair Pathways Full Network WP4946,0.6878628952700067,0.855570117955439,0.3201250271952119,"['DDB1', 'PRKDC', 'REV3L', 'GTF2H3']",0.8813419315012612,0,0,4
263,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6880379592633343,0.8742396593673966,0.3268880606390738,['RICTOR'],0.8813419315012612,0,0,1
264,Acute viral myocarditis WP4298,0.691548300113297,0.8389031078610604,0.30940615861533927,"['SGCD', 'JAK1']",0.8813419315012612,0,0,2
265,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7022556592188207,0.8391970802919708,0.2966207154443957,['ARRB2'],0.8813419315012612,0,0,1
266,Melatonin metabolism and effects WP3298,0.7022556592188207,0.8391970802919708,0.2966207154443957,['CRY2'],0.8813419315012612,0,0,1
267,Oxidative Damage WP3941,0.7022556592188207,0.8391970802919708,0.2966207154443957,['MAPK10'],0.8813419315012612,0,0,1
268,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7022556592188207,0.8391970802919708,0.2966207154443957,['CREB5'],0.8813419315012612,0,0,1
269,DNA damage response (only ATM dependent) WP710,0.7035043904268228,0.8275014459224985,0.2910166697384777,"['MAPK10', 'IRS1', 'WNT7A']",0.8813419315012612,0,0,3
270,Regulation of toll-like receptor signaling pathway WP1449,0.7115697825409393,0.8166833166833167,0.277902459393953,"['RNF31', 'MAPK10', 'ZMYND11']",0.8836393169477385,0,0,3
271,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7158265089814023,0.8068500842223469,0.2697440604901909,['JAK1'],0.8836393169477385,0,0,1
272,IL17 signaling pathway WP2112,0.7158265089814023,0.8068500842223469,0.2697440604901909,['JAK1'],0.8836393169477385,0,0,1
273,Prion disease pathway WP3995,0.7158265089814023,0.8068500842223469,0.2697440604901909,['CHD2'],0.8836393169477385,0,0,1
274,Glycolysis and Gluconeogenesis WP534,0.7287798862793791,0.7768991619356583,0.24579810072619412,['PFKP'],0.8963460645114991,0,0,1
275,MECP2 and Associated Rett Syndrome WP3584,0.739026505991318,0.7623067974073459,0.23053795850046804,"['CSRP1', 'NF1']",0.8984369537112218,0,0,2
276,ATM Signaling Pathway WP2516,0.7411438371861118,0.7490875912408759,0.22439709851700815,['AP3B2'],0.8984369537112218,0,0,1
277,Development of ureteric collection system WP5053,0.7411438371861118,0.7490875912408759,0.22439709851700815,['GLI1'],0.8984369537112218,0,0,1
278,miRNA regulation of prostate cancer signaling pathways WP3981,0.7411438371861118,0.7490875912408759,0.22439709851700815,['PDGFRB'],0.8984369537112218,0,0,1
279,Endometrial cancer WP4155,0.7477382653772218,0.7486288848263254,0.21762811982893787,"['CTNNA1', 'CTNNA2']",0.8997961375981939,0,0,2
280,Neural Crest Differentiation WP2064,0.7477382653772218,0.7486288848263254,0.21762811982893787,"['NOTCH2', 'FZD3']",0.8997961375981939,0,0,2
281,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7529451359130288,0.7231940599043544,0.20521565419476448,['JAK1'],0.8997961375981939,0,0,1
282,DNA Replication WP466,0.7529451359130288,0.7231940599043544,0.20521565419476448,['ORC3'],0.8997961375981939,0,0,1
283,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7642093427622827,0.6990267639902676,0.18797774662891506,['DOCK1'],0.9036440298627693,0,0,1
284,Vitamin D-sensitive calcium signaling in depression WP4698,0.7642093427622827,0.6990267639902676,0.18797774662891506,['GSR'],0.9036440298627693,0,0,1
285,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7642093427622827,0.6990267639902676,0.18797774662891506,['PPP3CB'],0.9036440298627693,0,0,1
286,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7749608588431862,0.6764186484577349,0.17244803419237414,['JAK1'],0.9036740810731965,0,0,1
287,MAPK Cascade WP422,0.7749608588431862,0.6764186484577349,0.17244803419237414,['MAPK10'],0.9036740810731965,0,0,1
288,p38 MAPK Signaling Pathway WP400,0.7749608588431862,0.6764186484577349,0.17244803419237414,['HMGN1'],0.9036740810731965,0,0,1
289,Parkinson's disease pathway WP2371,0.7749608588431862,0.6764186484577349,0.17244803419237414,['PRKN'],0.9036740810731965,0,0,1
290,Hepatitis B infection WP4666,0.7795403194390472,0.7477064220183486,0.18621693272239262,"['DDB1', 'MAPK10', 'JAK1', 'CREB5']",0.9058796125895134,0,0,4
291,Ferroptosis WP4313,0.7852229785598004,0.6552235401459854,0.1584248960554607,['FTH1'],0.9059102018594515,0,0,1
292,Integrated Cancer Pathway WP1971,0.7852229785598004,0.6552235401459854,0.1584248960554607,['JAK1'],0.9059102018594515,0,0,1
293,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7876311250588109,0.6869661641741841,0.16399628203720903,"['THRB', 'MAP4K5']",0.9059102018594515,0,0,2
294,Nephrotic syndrome WP4758,0.7950179397710363,0.6353129838531298,0.1457348258122441,['PLCE1'],0.9112960738191811,0,0,1
295,Ciliary landscape WP4352,0.8022713276243978,0.7661849655145766,0.1687969950311356,"['WDR26', 'RMND5A', 'BBS9', 'ARMC8', 'IQGAP1', 'BBIP1', 'EFHC2']",0.9164930081675323,0,0,7
296,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.813001445862414,0.6826325848064978,0.1413202298861718,"['NOTCH2', 'FZD3', 'WNT7A']",0.9256131326203836,0,0,3
297,TGF-beta Receptor Signaling WP560,0.8218073931140697,0.5822181670721817,0.11425986484224337,['JAK1'],0.9291981181578374,0,0,1
298,Interleukin-11 Signaling Pathway WP2332,0.8218073931140697,0.5822181670721817,0.11425986484224337,['JAK1'],0.9291981181578374,0,0,1
299,Spinal Cord Injury WP2431,0.8280891422988653,0.6251193756992005,0.1179190625034083,"['VCAN', 'PLA2G5']",0.9291981181578374,0,0,2
300,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8292111245886605,0.6609022556390978,0.12377409329532708,"['THRB', 'DEAF1', 'RORA']",0.9291981181578374,0,0,3
301,Glycogen Synthesis and Degradation WP500,0.8299365981172376,0.5664332215427106,0.10558653349000319,['PPP2R1B'],0.9291981181578374,0,0,1
302,Metabolic reprogramming in colon cancer WP4290,0.8376955865673815,0.5514790626200538,0.09766722123054726,['TKT'],0.9337245696762911,0,0,1
303,Modulators of TCR signaling and T cell activation WP5072,0.8451011892571312,0.5372917836421486,0.09042562056876247,['DGKZ'],0.9337245696762911,0,0,1
304,Senescence and Autophagy in Cancer WP615,0.8510681160719221,0.5896953935679893,0.09509611384140987,"['GSN', 'ATG10']",0.9337245696762911,0,0,2
305,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8521694732212202,0.5238138686131387,0.08379443107187846,['JAK1'],0.9337245696762911,0,0,1
306,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8521694732212202,0.5238138686131387,0.08379443107187846,['ATG10'],0.9337245696762911,0,0,1
307,PPAR signaling pathway WP3942,0.8521694732212202,0.5238138686131387,0.08379443107187846,['ACOX1'],0.9337245696762911,0,0,1
308,22q11.2 copy number variation syndrome WP4657,0.856358820787562,0.5814543977249644,0.09016369571350469,"['PRKN', 'CBX5']",0.9337245696762911,0,0,2
309,Wnt Signaling Pathway WP363,0.8589157762600897,0.5109934128538366,0.07771413191023813,['ARRB2'],0.9337245696762911,0,0,1
310,G1 to S cell cycle control WP45,0.8589157762600897,0.5109934128538366,0.07771413191023813,['ORC3'],0.9337245696762911,0,0,1
311,Glucocorticoid Receptor Pathway WP2880,0.8653547398764194,0.49878345498783455,0.07213194453621265,['MFGE8'],0.9376995091265381,0,0,1
312,Androgen receptor signaling pathway WP138,0.8712172048110668,0.5580499695307739,0.07693497820453347,"['NCOA1', 'PLPP1']",0.9410262757093893,0,0,2
313,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.877365922353186,0.47602853351028535,0.062279351120655746,['NAP1L1'],0.9446315625999382,0,0,1
314,ErbB signaling pathway WP673,0.880323860746846,0.5434601961110188,0.06927237977999412,"['MAPK10', 'NCK2']",0.9446315625999382,0,0,2
315,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8829642202343636,0.4654095701540957,0.05792980838932222,['MAPK10'],0.9446315625999382,0,0,1
316,Translation Factors WP107,0.8883073930560973,0.45525230085687085,0.053918913671058416,['EIF4G3'],0.9459433278393206,0,0,1
317,Fragile X Syndrome  WP4549,0.8898042579378772,0.5753100110898276,0.06716961578933979,"['SYNGAP1', 'KCND2', 'NF1']",0.9459433278393206,0,0,3
318,7q11.23 copy number variation syndrome WP4932,0.8928737829826322,0.5229433272394881,0.05925473379323863,"['HSPA2', 'DEK']",0.9462215876262486,0,0,2
319,Gastrin signaling pathway WP4659,0.9077103098262418,0.49786715417428395,0.048208473216511685,"['IRS1', 'ARRB2']",0.9553096213400709,0,0,2
320,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9115846478280322,0.41044081866323173,0.037994844237176445,['ANGPT1'],0.9553096213400709,0,0,1
321,AMP-activated protein kinase (AMPK) signaling WP1403,0.9156231682280205,0.4025126333520494,0.03548164454276307,['SLC2A4RG'],0.9553096213400709,0,0,1
322,Apoptosis WP254,0.9156231682280205,0.4025126333520494,0.03548164454276307,['MAPK10'],0.9553096213400709,0,0,1
323,MET in type 1 papillary renal cell carcinoma WP4205,0.9156231682280205,0.4025126333520494,0.03548164454276307,['ALK'],0.9553096213400709,0,0,1
324,Toll-like Receptor Signaling Pathway WP75,0.9266669755598154,0.38045786330457865,0.02897606183831165,['MAPK10'],0.9617360682253581,0,0,1
325,Melanoma WP4685,0.9300176821335114,0.37363138686131386,0.02710758480585894,['NF1'],0.9617360682253581,0,0,1
326,Proteasome Degradation WP183,0.9332155505918017,0.36704443590728647,0.02536977198366415,['PSMD6'],0.9617360682253581,0,0,1
327,T-cell receptor (TCR) signaling pathway WP69,0.9362675403247895,0.3606846211930531,0.02375252853074158,['VAV3'],0.9617360682253581,0,0,1
328,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9391802943055028,0.3545403934182853,0.022246633771687143,['SEC31A'],0.9617360682253581,0,0,1
329,Genes related to primary cilium development (based on CRISPR) WP4536,0.9414824651051926,0.4351767215112736,0.02624096286322385,"['CEP19', 'BBS9']",0.9617360682253581,0,0,2
330,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9446131708682299,0.3428562881416776,0.019535875283196426,['MAPK10'],0.9617360682253581,0,0,1
331,Non-small cell lung cancer WP4255,0.9446131708682299,0.3428562881416776,0.019535875283196426,['ALK'],0.9617360682253581,0,0,1
332,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9540685021094824,0.32164514317798987,0.015123691900332211,['PPP3CB'],0.965818248081794,0,0,1
333,TGF-beta Signaling Pathway WP366,0.9570740042379235,0.4014203346927296,0.01761214100797354,"['JUND', 'NEDD4L']",0.965818248081794,0,0,2
334,B Cell Receptor Signaling Pathway WP23,0.9600863890427328,0.3073744096178617,0.012519977521013555,['INPP5D'],0.965818248081794,0,0,1
335,Joubert Syndrome WP4656,0.9600863890427328,0.3073744096178617,0.012519977521013555,['BBS9'],0.965818248081794,0,0,1
336,Metapathway biotransformation Phase I and II WP702,0.9761568148559668,0.2643213526748591,0.0063786120061337746,['GSR'],0.9790620434716096,0,0,1
337,IL-18 signaling pathway WP4754,0.9846737093399184,0.3758771349132795,0.00580540439759392,"['TSHZ1', 'ZDHHC7', 'DEK']",0.9846737093399184,0,0,3
